Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $40.6 million.

  • HUTCHMED (China)'s Other Non-Current Assets rose 897.68% to $40.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $40.6 million, marking a year-over-year increase of 897.68%. This contributed to the annual value of $32.4 million for FY2024, which is 879505.49% up from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s Other Non-Current Assets is $40.6 million, which was up 897.68% from $4.8 billion recorded in Q4 2024.
  • HUTCHMED (China)'s 5-year Other Non-Current Assets high stood at $4.8 billion for Q4 2024, and its period low was $5.1 million during Q4 2022.
  • In the last 5 years, HUTCHMED (China)'s Other Non-Current Assets had a median value of $38.4 million in 2023 and averaged $950.2 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Other Non-Current Assets tumbled by 7637.15% in 2022, and later skyrocketed by 8735197.47% in 2023.
  • HUTCHMED (China)'s Other Non-Current Assets (Quarter) stood at $21.6 million in 2021, then tumbled by 76.37% to $5.1 million in 2022, then skyrocketed by 87351.97% to $4.5 billion in 2023, then grew by 7.97% to $4.8 billion in 2024, then crashed by 99.16% to $40.6 million in 2025.
  • Its last three reported values are $40.6 million in Q2 2025, $4.8 billion for Q4 2024, and $37.3 million during Q2 2024.